The clear cell histologic subtype of stage I ovarian cancer is associated with a disproportionately high risk for capsule rupture during surgery compared with other histologies.
A new study found a link between posttraumatic stress disorder and ovarian cancer.
A new combination may help with overall and progression-free survival in liver cancer.
A combination of trifluridine and tipiracil showed some gains in overall survival for patients with metastatic gastric cancer or gastroesophageal junction cancer.
New guidelines for exercise for patients with cancer have been released.
The combination of trilaciclib and chemotherapy was generally well–tolerated with promising activity in a phase II trial of patients with metastatic triple-negative breast cancer.
A recent report highlighted the progress made globally in preventing cancer. However, improvements are still needed.
Pembrolizumab offers survival advantages at a much lower cost over atezolizumab.
A liquid biopsy may be able to predict the efficacy of EGFR-targeted tyrosine kinase inhibitors in patients with non–small cell lung cancer.
A new combination may offer better survival for patients with BRAFV600E-mutated metastatic colorectal cancer.